Genesis Research Group Unveils Enhanced US Market Access Data Analytics
12 nov. 2024 07h00 HE
|
Genesis Research Group
Expanded tech-enabled data analytics capabilities strengthen Genesis Research Group’s integrated approach to market access, helping life sciences companies better navigate US market access hurdles...
Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program
12 juin 2024 09h30 HE
|
Genesis Research Group
Genesis Research Group Announces Participation of CEODavid W. Miller in New ITN Business Healthcare Program Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in...
Genesis Research Group Announces Appointment of David W. Miller as CEO
06 mars 2024 07h00 HE
|
Genesis Research Group
Genesis Research Group Announces Appointment of David W. Miller as CEO A seasoned executive with more than 25 years in the biopharmaceutical industry, David Miller will lead the Group’s next phase of...
Genesis Research Strengthens Board of Directors with Appointments of Professor Carole Longson MBE and Dr. S. Yin Ho, M.D.,M.B.A.
17 janv. 2023 07h33 HE
|
Genesis Research
Genesis Research Strengthens Board of Directors with Appointments of Professor Carole Longson MBE and Dr. S. Yin Ho, M.D.,M.B.A. HOBOKEN, NJ, 17 January 2023 - Genesis Research (“Genesis” or “the...
Genesis Research to Acquire Market Access Transformation, a Leading Provider of Technology-Enabled Payer Research Platforms
16 mai 2022 09h00 HE
|
Genesis Research
Genesis Research to Acquire Market Access Transformation, a Leading Provider of Technology-Enabled Payer Research Platforms Combined offering will enable life sciences companies to generate insights...